Company profile
Turn Therapeutics Inc.
NASDAQ:TTRXBiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04951349 | phase2 | completed | 2021-01-21 | 2021-05-30 | Turn Therapeutics | Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19. |
FDA applications (0)
No records yet.